Search

This work studies the use of Cu/Co‐MOFs for the removal of doxycycline hydrochloride (DOC) in wastewater. Cu/Co‐MOFs were prepared using a solvothermal method and characterized by XRD, SEM, and TG. According to the experimental results, the maximum DOC adsorption capacity of Cu/Co‐MOFs within 5 h was 268.5 mg/g. The pseudo‐second‐order (PSO) kinetic model shows that the R2 are all greater than 0.99, which proves that the theory DOC adsorption by Cu/Co‐MOFs is consistent with practice. According to the Freundlich isotherm model, the adsorption of DOC by Cu/Co‐MOFs is a multilayer adsorption. Thus, the results show that Cu/Co‐MOFs have practical application value in removing DOC. [ABSTRACT FROM AUTHOR]

[Display omitted] • Both ion-sharing interface and directional doping are employed to construct a heterostructured HER electro-catalyst. • Electronic structure and coordination chemistry of Mo and Co centers are tailored to optimize adsorption/desorption of H ads and OH– intermediates for lowering the energy barriers. • Mo center with more coordination vacancies are main active sites responsible for rate-limiting step in the Volmer-Heyrovsky regime. • This catalyst presents an extremely low overpotential of 37 mV at 10 mA cm−2 in alkaline media, and excellent performance for overall water splitting. Interfacing and doping can effectively harmonize the electronic and coordination states of active centers in the electrocatalysts. Herein, we prepare heterostructured N-MoS 2 /Se-CoS 2 electrocatalyst with ion-sharing interfaces and directional doping to activate inert basal phases for hydrogen evolution reaction (HER). Based on experimental and theoretical results, their synergistic effects on electron redistribution, electronic structure and coordination chemistry are investigated; furthermore, roles of each component and bridged Mo-S-Co sites at the phase interfaces as active sites in optimizing the adsorption/desorption of essential reaction intermediates H* and OH–, as well as the free energies of unit reaction steps in the HER, are elucidated in depth. The N-MoS 2 /Se-CoS 2 catalyst needs only 37 mV to give current density of 10 mA cm−2 with a low Tafel slope of 49.4 mV dec−1; more importantly, the catalyst delivers a long-term durability for HER in alkaline condition and comparable performance with commercial RuO 2|| Pt/C system in a two-electrode assembled electrolyzer. This work provides more insights into the design and preparation of high-performance heterostructured electrocatalysts. [ABSTRACT FROM AUTHOR]

Fe-MOFs were prepared using a solvothermal method, and were characterized by scanning electron microscopy. We explored the application of Fe-MOFs as an adsorbing material for the removal of Rhodamine B (RhB) from aqueous solutions. The experimental data were simulated by dynamics and the results showed that the pseudo–second-order kinetics model was appropriate for analysis of RhB removal. We studied the adsorption capacity of MOF materials under different masses, concentrations, and pH conditions. When the pH was 6, the maximum adsorption capacity within 4 h was 135 mg/g. In summation, the removal of RhB from wastewater using MOFs is feasible, inexpensive, and effective. Hence, our findings indicate that MOFs have a broad application in the purification of wastewater. [ABSTRACT FROM AUTHOR]

Cardiac injury is a common complication following traumatic brain injury (TBI) that can lead to poor clinical outcomes. Angiotensin II type 2 receptor (AT2R) activation exerts protective roles in the brain and heart, yet its potential impact on TBI or TBI-induced cardiac deficits remains elusive. The goal of this study was to investigate the influence of AT2R activation on recovery after TBI-induced cognitive and cardiac injury using the selective nonpeptide AT2R agonist compound 21 (C21). TBI was induced by cortical impact injury in male adult C57BL/6J mice, and the mice received C21 (0.03 mg/kg, intraperitoneally) starting from 24 h after TBI and continuing once daily. C21 facilitated cognitive function recovery until 1 month after TBI. C21 alleviated blood-brain barrier leakage and brain edema and inhibited the expression of proinflammatory cytokines in the brain after 3 consecutive days of treatment. C21 improved cerebral blood flow after 1 month, although the lesion volume was not affected. C21 also reduced the expression of proinflammatory cytokines in the heart after a 3-day consecutive treatment. Meanwhile, C21 benefited cardiac function, as identified by increased left ventricular ejection fraction 1 month after TBI. In addition, C21 alleviated TBI-induced cardiac hypertrophy and fibrosis; however, blood pressure was not affected. Our results demonstrate that AT2R activation ameliorates TBI-induced neurological and cardiac deficits. [ABSTRACT FROM AUTHOR]

A novel dual-drive MEMS device integrated with both a thermal actuator and an electrostatic actuator is proposed and fabricated, which realizes the convenient in-situ electro-mechanical test for nanomaterials. The drive mode can be agilely selected to analyze different mechanical properties and the accuracy of the test can be verified by self-contrast of the two driving modes. Using the nanomanipulator as the transfer method, coupled mechanical and electrical tests are carried out for TiO 2 nanowires. The measured Young's modulus of the nanowire in the two driving modes are 78.2 GPa and 85.6 GPa, and the fracture stress are 562 MPa and 584 MPa, respectively. The electron beam (e-beam) irradiation effect on electrical properties is investigated. Meanwhile, the resistance of the nanowires is determined as a variable of strain, which demonstrates the changes in resistance are the result of the loaded strains. The resistance decreases slightly after 2000 cycles of tensile, which is believed to be a delayed response brought about by electron beam irradiation. The experiment results indicate that the proposed MEMS device will facilitate the in-situ test of 1D/2D nanomaterials. [Display omitted] • A novel dual-drive MEMS device integrated both a thermal actuator and an electrostatic actuator was reported. • The drive mode can be conveniently selected. • The accuracy of the test can be verified by the two driving modes. • The coupled mechanical and electrical tests can be carried out. [ABSTRACT FROM AUTHOR]

In the most primitive jawless vertebrate lamprey, the complement-dependent cytotoxicity regulated by variable lymphocyte receptors (VLRs) plays an important role in the adaptive immunity. Our previous studies have shown that the lamprey pore-forming protein (LPFP) acted as the terminal effector of VLR to lyse and kill the target cells. Here, the recombinant GST-LPFP protein was expressed and purified in prokaryotic expression system, and then used as the immunogen to produce mouse monoclonal antibody and rabbit polyclonal antibody. With these antibodies, we proved that LPFP existed as homodimers in the lamprey serum, and could be recruited to the membrane of target cells after stimulation. In conclusion, the antibodies we produced could specifically recognize the LPFP protein, which could be the useful tools to further study the pore-forming mechanism of LPFP. • LPFP protein was successfully expressed and purified via the prokaryotic expression system. • The rabbit polyclonal antibody and mouse monoclonal antibody with very high titers against LPFP were produced. • LPFP existed as a homodimer in the lamprey serum. • LPFP was recruited to the membrane of target cells to directly participate in the complement defense system in lamprey. [ABSTRACT FROM AUTHOR]

The early stages of brain injury can induce acute liver injury, which can be recovered in the short term. Continued medication treatment during hospitalization for brain injury alleviates the prognosis and contributes to a high incidence of drug-induced liver injury (DILI). We hypothesize that there is an interaction between changes in the hepatic environment after brain injury and liver injury produced by intensive drug administration, leading to an upregulation of the organism's sensitivity to DILI. In this study, mice models of TBI were established by controlled cortical impact (CCI) and models of DILI were constructed by acetaminophen (APAP). All mice were divided into four groups: Sham, TBI, APAP, and TBI+APAP, and related liver injury indicators in liver and serum were detected by Western blot, Quantitative real-time PCR (qRT-PCR), and immunohistochemical staining. The results suggested that liver injury induced in the early stages of brain injury recovered in 3 days, but this state could still significantly aggravate DILI, represented by higher liver enzymes (aspartate aminotransferase [AST] and alanine aminotransferase [ALT]), oxidative stress (increase in malondialdehyde [MDA] concentration and deregulation of glutathione [GSH] and superoxide dismutase [SOD] activities), inflammatory response (activation of the HMGB1/TLR4/NF-κB signaling pathway, and increased messenger RNA [mRNA] and protein levels of pro-inflammatory cytokines including tumor necrosis factor alpha [TNF-α], interleukin [IL]-6, and IL-1β), and apoptosis (TUNEL assay, upregulation of Bax protein and deregulation of Bcl-2 protein). In summary, our results suggested that TBI is a potential susceptibility factor for DILI and exacerbates DILI. [ABSTRACT FROM AUTHOR]

Aim: We aim to identify the specific CD4+ T‐cell subtype influenced by brain‐to‐CLN signaling and explore their role during the acute phase of traumatic brain injury (TBI). Method: Cervical lymphadenectomy or cervical afferent lymphatic ligation was performed before TBI. Cytokine array and western blot were used to detect cytokines, while the motor function was assessed using mNss and rotarod test. CD4+ T‐cell subtypes in blood, brain, and CLNs were analyzed with Cytometry by time‐of‐flight analysis (CyTOF) or fluorescence‐activated cell sorting (FACS). Brain edema and volume changes were measured by 9.4T MRI. Neuronal apoptosis was evaluated by terminal deoxynucleotidyl transferase‐mediated dUTP nick end labeling (TUNEL) staining. Results: Cervical lymphadenectomy and ligation of cervical lymphatic vessels resulted in a decreased infiltration of CD4+ T cells, specifically CD11b‐positive CD4+ T cells, within the affected region. The population of CD4+CD11b+ T cells increased in ligated CLNs, accompanied by a decrease in the average fluorescence intensity of sphingosine‐1‐phosphate receptor‐1 (S1PR1) on these cells. Administration of CD4+CD11b+ T cells sorted from CLNs into the lateral ventricle reversed the attenuated neurologic deficits, brain edema, and lesion volume following cervical lymphadenectomy. Conclusion: The infiltration of CD4+CD11b+ T cells exacerbates secondary brain damage in TBI, and this process is modulated by brain‐to‐CLN signaling. [ABSTRACT FROM AUTHOR]

This study aimed to investigate the predictive factors of therapeutic efficacy for chronic subdural hematoma (CSDH) patients receiving atorvastatin combined with dexamethasone therapy by using clinical imaging characteristics in conjunction with computed tomography (CT) texture analysis (CTTA). Clinical imaging characteristics and CT texture parameters at admission were retrospectively investigated in 141 CSDH patients who received atorvastatin combined with dexamethasone therapy from June 2019 to December 2022. The patients were divided into a training set (n = 81) and a validation set (n = 60). Patients in the training data were divided into two groups based on the effectiveness of the treatment. Univariate and multivariate analyses were performed to assess the potential factors that could indicate the prognosis of CSDH patients in the training set. The receiver operating characteristic (ROC) curve was used to analyze the predictive efficacy of the significant factors in predicting the prognosis of CSDH patients and was validated using a validation set. The multivariate analysis showed that the hematoma density to brain parenchyma density ratio, singal min (minimum) and singal standard deviation of the pixel distribution histogram, and inhomogeneity were independent predictors for the prognosis of CSDH patients based on atorvastatin and dexamethasone therapy. The area under the ROC curve between the two groups was between 0.716 and 0.806. As determined by significant factors, the validation's accuracy range was 0.816 to 0.952. Clinical imaging characteristics in conjunction with CTTA could aid in distinguishing patients with CSDH who responded well to atorvastatin combined with dexamethasone. [ABSTRACT FROM AUTHOR]

Background: We have recently showed that atorvastatin (ATO) combined with low dose of dexamethasone (DEX) was more efficacious in treating patients with chronic subdural haematoma (CSDH) than ATO monotherapy. This study was designed to investigate the underlying mechanisms of the improved efficacy of this combined therapy.Methods: Mass spectrometry was performed to quantitatively detect drugs in haematoma fluids and serum samples from CSDH patients and also in cultured macrophages after treatment with either ATO alone or in combination with DEX. The differentiation and apoptosis of macrophages were evaluated using flow cytometry. The expression of cytokines, chemokines and angiogenesis-related proteins was evaluated using proteome profile arrays, immunoblots and ELISA, respectively.Results: ATO was detected in haematoma fluids and serum samples, whose levels were increased significantly in samples collected from patients treated with both ATO and DEX. ATO was also increased in cultured macrophages treated with ATO and DEX. The numbers of M1-polarized macrophages were higher than the M2 phenotype in the haematoma fluids of patients. Cultured macrophages treated with ATO and DEX had reduced numbers of M1-polarized macrophages, increased numbers of M2-polarized macrophages as compared to monotherapies, and decreased rate of apoptosis induced by high-dose DEX. DEX enhanced the anti-inflammatory and anti-angiogenic activity of ATO by suppressing VEGFA and other inflammatory angiogenic factors. Consistent with the finding, patients responded well to the drug treatments had lower serum levels of VEGFA.Conclusions: We have shown for the first time that ATO given orally was detected in CSDH haematoma fluids. DEX enhances the anti-inflammatory and anti-angiogenic effects of ATO, primarily by increasing the presence of ATO in haematoma and macrophages and by regulating the functions of macrophages. [ABSTRACT FROM AUTHOR]

Pyrolytic reforming of toluene over Ni-based catalysts loaded on nano-sized and micro-sized γ-Al 2 O 3 is investigated in a fixed bed reactor under the temperature from 500 °C to 800 °C. The physicochemical properties of γ-Al 2 O 3 and Ni/Al 2 O 3 catalysts were characterized by HRTEM, XPS, XRD and H 2 -pulse chemisorption. The metal Ni loaded on micro-sized γ-Al 2 O 3 gave the steady toluene conversion of more than 80% and graphite yield of 87.3% after 1 h of reforming reaction. The rapid decrease of H 2 yield from 5.2 mmol/g-toluene to 0.4 mmol/g-toluene over Ni/nano-Al 2 O 3 was obtained during the 1 h of reforming reaction at 500 °C. The particle size of metal Ni over nano-sized and micro-sized γ-Al 2 O 3 were centered at 7.8 nm and 28.8 nm, respectively. The metastable NiC x crystallites were observed over the spent Ni/nano-Al 2 O 3 catalyst, while only metal Ni were obtained over the spent Ni/micro-Al 2 O 3 catalyst. Ni0+ particle size-dependent crystalline phase was evidenced by MD simulations, where incorporation of more carbon atoms was achieved on small Ni particles. The energy barrier for –CH 2 dehydrogenation over Ni 32 C, Ni 4 C and Ni 3 C were estimated to be 90.2, 105.1 and 116.0 kJ/mol through the DFT simulation, respectively. It can be concluded that the crystalline Ni phase was maintained over Ni/micro-Al 2 O 3 with large Ni particle size, prolonging the catalytic endurance and promoting the CNTs (Carbon Nanotubes) growth without the deposition of unexpected amorphous carbon. • The influence of γ-Al 2 O 3 on Ni/Al 2 O 3 catalytic reforming performance was investigated. • Ni0+ particle size-dependent pyrolytic reforming for co-production of H 2 and CNTs was revealed. • The carbon solubility on Ni particles with different sizes was simulated. [ABSTRACT FROM AUTHOR]

Background: The discovery of the glymphatic system and meningeal lymphatic vessels challenged the traditional view regarding the lack of a lymphatic system in the central nervous system. It is now known that the intracranial lymphatic system plays an important role in fluid transport, macromolecule uptake, and immune cell trafficking. Studies have also shown that the function of the intracranial lymphatic system is significantly associated with neurological diseases; for example, an impaired intracranial lymphatic system can lead to Tau deposition and an increased lymphocyte count in the brain tissue of mice with subarachnoid hemorrhage. Methods: In this study, we assessed the changes in the intracranial lymphatic system after intracerebral hemorrhage and the regulatory effects of repeated transcranial magnetic stimulation on the glymphatic system and meningeal lymphatic vessels in an intracerebral hemorrhage (ICH) model of male mice. Experimental mice were divided into three groups: Sham, ICH, and ICH + repeated transcranial magnetic stimulation (rTMS). Three days after ICH, mice in the ICH+rTMS group were subjected to rTMS daily for 7 days. Thereafter, the function of the intracranial lymphatic system, clearance of RITC‐dextran and FITC‐dextran, and neurological functions were evaluated. Results: Compared with the Sham group, the ICH group had an impaired glymphatic system. Importantly, rTMS treatment could improve intracranial lymphatic system function as well as behavioral functions and enhance the clearance of parenchymal RITC‐dextran and FITC‐dextran after ICH. Conclusion: Our results indicate that rTMS can abrogate ICH‐induced brain parenchymal metabolite clearance dysfunction by regulating intracranial lymphatic drainage. [ABSTRACT FROM AUTHOR]

This work studies the use of Fe/Ni-MOFs for the removal of ciprofloxacin (CIP) in wastewater. Fe/Ni-MOFs are prepared by the solvothermal method and characterized by X-ray diffraction (XRD), a scanning electron microscope (SEM), Fourier transform infrared spectroscopy (FT-IR), and a thermal gravimetric analyzer (TG). Under the conditions of the concentration of 50 ppm, a mass of 30 mg, and a temperature of 30 °C, the maximum adsorption capacity of ciprofloxacin removal within 5 h was 232.1 mg/g. The maximum removal rate was 94.8% when 40 mg of the Fe/Ni-MOFs was added to the solution of 10 ppm ciprofloxacin. According to the pseudo-second-order (PSO) kinetic model, the R2 values were all greater than 0.99, which proved that the adsorption theory of ciprofloxacin by Fe/Ni-MOFs was consistent with the practice. The adsorption results were mainly affected by solution pH and static electricity, as well as other factors. The Freundlich isotherm model characterized the adsorption of ciprofloxacin by Fe/Ni-MOFs as multilayer adsorption. The above results indicated that Fe/Ni-MOFs were effective in the practical application of ciprofloxacin removal. [ABSTRACT FROM AUTHOR]

The persistent dysregulation and accumulation of poisonous proteins from destructive neural tissues and cells activate pathological mechanisms after traumatic brain injury (TBI). The lymphatic drainage system of the brain, composed of the glymphatic system and meningeal lymphatic vessels (MLVs), plays an essential role in the clearance of toxic waste after brain injury. The neuroprotective effect of interleukin 33 (IL-33) in TBI mice has been demonstrated; however, its impact on brain lymphatic drainage is unclear. Here, we established a fluid percussion injury model to examine the IL-33 administration effects on neurological function and lymphatic drainage in the acute brain of TBI mice. We verified that exogenous IL-33 could improve the motor and memory skills of TBI mice and demonstrated that in the acute phase, it increased the exchange of cerebrospinal and interstitial fluid, reversed the dysregulation and depolarization of aquaporin-4 in the cortex and hippocampus, improved the drainage of MLVs to deep cervical lymph nodes, and reduced tau accumulation and glial activation. We speculate that the protective effect of exogenous IL-33 on TBI mice's motor and cognitive functions is related to the enhancement of brain lymphatic drainage and toxic metabolite clearance from the cortex and hippocampus in the acute stage. These data further support the notion that IL-33 therapy may be an effective treatment strategy for alleviating acute brain injury after TBI. [ABSTRACT FROM AUTHOR]

The glymphatic-lymphatic fluid transport system (GLFTS) consists of glymphatic pathway and cerebrospinal fluid (CSF) lymphatic outflow routes, allowing biological liquids from the brain parenchyma to access the CSF along with perivascular space and to be cleaned out of the skull through lymphatic vessels. It is known that increased local pressure due to physical compression of tissue improves lymphatic transport in peripheral organs, but little is known about the exact relationship between increased intracranial pressure (IICP) and GLFTS. In this study, we verify our hypothesis that IICP significantly impacts GLFTS, and this effect depends on severity of the IICP. Using a previously developed inflating balloon model to induce IICP and inject fluorescent tracers into the cisterna magna, we found significant impairment of the glymphatic circulation after IICP. We further found that cerebrovascular occlusion occurred, and cerebrovascular pulsation decreased after IICP. IICP also interrupted the drainage of deep cervical lymph nodes and dorsal meningeal lymphatic function, enhancing spinal lymphatic outflow to the sacral lymph nodes. Notably, these effects were associated with the severity of IICP. Thus, our findings proved that the intensity of IICP significantly impacts GLFTS. This may have translational applications for preventing and treating related neurological disorders. [ABSTRACT FROM AUTHOR]

Although first-line epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapy is effective for treating EGFR-mutant non-small cell lung cancer (NSCLC), it is now understood that drug-tolerant persister (DTP) cells escaping from initial treatment eventually drives drug resistance. Here, through integration of metabolomics and transcriptomics, we found that the neurotransmitter acetylcholine (ACh) was specifically accumulated in DTP cells, and demonstrated that treatment with EGFR-TKI heightened the expression of the rate-limiting enzyme choline acetyltransferase (ChAT) in ACh biosynthesis via YAP mediation. Genetic and pharmacological manipulation of ACh biosynthesis or ACh signaling could predictably regulate the extent of DTP formation in vitro and in vivo. Strikingly, pharmacologically targeting ACh/M3R signaling with an FDA-approved drug, darifenacin, retarded tumor relapse in vivo. Mechanistically, upregulated ACh metabolism mediated drug tolerance in part through activating WNT signaling via ACh muscarinic receptor 3 (M3R). Importantly, we showed that aberrant ACh metabolism in patients with NSCLC played a potential role in predicting EGFR-TKI response rate and progression-free survival. Our study therefore defines a therapeutic strategy - targeting the ACh/M3R/WNT axis - for manipulating EGFR TKI drug tolerance in the treatment of NSCLC. [ABSTRACT FROM AUTHOR]

Background: With over 2 million new cases annually, stroke is associated with the higher amount of disability-adjusted life-years lost than any other disease in China; however, the relationship between sleep time and stroke has not been concluded yet. Aim of this study was to analyze the relationship between sleep duration and stroke history in middle-aged and elderly people in Guiyang, China. Methods: This study was a cross-sectional survey carried out in 40– 99-years-old permanent residents of Guiyang. Yunyan, Wudang, and Baiyun districts and Xiuwen County were selected by stratified multilevel sampling for a face-to-face survey. Demographics, history of stroke, and self-reported sleep behavior data were collected, and multivariable logistic regression models were used to gradually adjust possible confounding factors. Results: A total of 5065 participants were included, of them 126 (2.5%) had a history of stroke. Short sleep (< 7 h) was observed in 11.0%, sufficient sleep (7– 9 h) in 69.4%, and long sleep (> 9 h) in 19.6%. Sleep duration and stroke prevalence showed a U-shaped distribution. When taking the sleep duration of 7– 9 h as a reference, sleep duration > 9 h was associated with stroke (all P < 0.05) in the univariable model (OR = 2.68, 95% CI: 1.83– 3.93) and in the multivariable models 1 (OR = 2.35, 95% CI: 1.59– 3.47), 2 (OR = 2.27, 95% CI: 1.53– 3.37), 3 (OR = 2.25, 95% CI: 1.51– 3.33), and 4 (OR = 2.11, 95% CI: 1.39– 3.19). There were no significant differences between the < 7 and 7– 9 h groups (P > 0.05). Conclusion: Thus, long sleep duration (> 9 h) is independently associated with history of stroke in middle-aged and elderly people in Guiyang. [ABSTRACT FROM AUTHOR]

Purpose: Follistatin-related gene 3 (FSTL3), an established oncogene, can modulate target gene expression via members of the transforming growth factor β (TGF-β) superfamily. The present study was conducted to evaluate the expression of FSTL3 in gastric cancer (GC) and to determine its prognostic significance. We also evaluated the possible mechanisms involved in the oncogenic role of FSTL3 in gastric carcinogenesis and development. Methods: We obtained data from the Human Protein Atlas, MethSurv, cBioPortal, UALCAN, TIMER, GEPIA, STRING, GeneMANIA, ONCOMINE, and MEXPRESS databases and examined it using R software. RNAi was used to establish stable FSTL3-knockdown (shFSTL3) and overexpression (OE) cell strains. Western blot; enzyme-linked immunosorbent (ELISA); and immunohistochemical (ICH), immunofluorescence, and phalloidin staining were used for examining protein expression. Cell invasion and migration were determined using transwell and scratch-wound assays. After tumor-associated macrophage (TAM) generation, co-culturing of cancer cells with TAMs was performed to confirm the relationship between FSTL3 and TAMs. Results: In GC patients, FSTL3 mRNA and protein levels were upregulated. FSTL3 expression was significantly linked to cancer stage as well as to pathological tumor grade in GC. Moreover, a high expression of FSTL3 was associated with a dismal survival duration in patients with GC. Furthermore, functional enrichment analysis demonstrated that FSTL3 overexpression could activate epithelial–mesenchymal transition (EMT) by promoting F-actin expression and BMP/SMAD signaling. Finally, immunofluorescence staining confirmed that the overexpression of FSTL3 promoted the proliferation of M2 TAMs. Conclusion: Taken together, our findings suggest that FSTL3 may be involved in GC progression via the promotion of BMP/SMAD signaling-mediated EMT and M2 macrophage activation. [ABSTRACT FROM AUTHOR]